• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Genentech

Genentech

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Roche receives FDA clearance for next generation cobas MRSA/SA Test

    Roche receives FDA clearance for next generation cobas MRSA/SA Test

  2. Research and Markets: Lung Cancer Clinical Trial Overview 2014

    Research and Markets: Lung Cancer Clinical Trial Overview 2014

  3. Agiliance Becomes a Board and Business Standard for Managing Cyber Security Operational Risks in 2014

    Agiliance Becomes a Board and Business Standard for Managing Cyber Security Operational Risks in 2014

  4. Workers Get Help Climbing the Corporate Ladder

    Workers Get Help Climbing the Corporate Ladder

  5. ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline

    ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline

  6. Research and Markets: Global Venlafaxine Industry Report 2015-2020

    Research and Markets: Global Venlafaxine Industry Report 2015-2020

  7. OncoSec Medical Plans to Initiate Pilot Study in Triple Negative Breast Cancer

    OncoSec Medical Plans to Initiate Pilot Study in Triple Negative Breast Cancer

  8. AC Immune Strikes Potential $509 Million Development Deal

    AC Immune Strikes Potential $509 Million Development Deal

  9. Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology

    Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology

  10. AVEO Announces Executive Transition and Corporate Restructuring

    AVEO Announces Executive Transition and Corporate Restructuring

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.